HHS-NIH11 · health
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists...
Deadline
2026-09-07
Funding range
Not listed
Days remaining
59 days
Cost-sharing required
No
Who can apply
- public_and_state_institutions_of_higher_education
- independent_school_districts
- private_institutions_of_higher_education
- for_profit_organizations_other_than_small_businesses
- city_or_township_governments
- special_district_governments
- other_native_american_tribal_organizations
- small_businesses
- other
- federally_recognized_native_american_tribal_governments
- state_governments
- public_and_indian_housing_authorities
- nonprofits_non_higher_education_with_501c3
- nonprofits_non_higher_education_without_501c3
- county_governments
Fit assessment
Overall fit66
Eligibility95
Topic48
Urgency35
- · Eligibility score 95/100 based on applicant-type gates.
- · Topic fit 48/100 for education, youth, community keywords.
- · Deadline urgency 35/100 with 99 days remaining.
- · Application burden appears low.
Want the full application brief?
One-page grant pack with eligibility checklist, deadline timeline, required documents, application outline, burden estimate, risk flags. Delivered by email within 24 hours.